Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Glaukos Corp
(NY:
GKOS
)
130.00
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
130.00
Bid (Size)
52.00 (2)
Ask (Size)
206.70 (1)
Prev. Close
130.00
Today's Range
130.00 - 130.00
52wk Range
59.22 - 130.13
Shares Outstanding
54,950,459
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Glaukos Announces Participation in Upcoming Investor Conferences
August 16, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)
August 01, 2024
Via
Benzinga
Performance
YTD
+68.66%
+68.66%
1 Month
+5.89%
+5.89%
3 Month
+20.67%
+20.67%
6 Month
+40.10%
+40.10%
1 Year
+74.61%
+74.61%
More News
Read More
Meta To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Thursday
August 01, 2024
Via
Benzinga
GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q2 2024
July 31, 2024
Via
InvestorPlace
Glaukos Announces Second Quarter 2024 Financial Results
July 31, 2024
From
Glaukos Corporation
Via
Business Wire
10 Analysts Have This To Say About Glaukos
July 10, 2024
Via
Benzinga
Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings)
May 22, 2024
Via
Benzinga
Analyst Ratings For Glaukos
April 08, 2024
Via
Benzinga
7 Leading MedTech Stocks for Next-Gen Health Solutions
July 31, 2024
Via
InvestorPlace
This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
July 10, 2024
Via
Benzinga
Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31
July 10, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
June 14, 2024
From
Glaukos Corporation
Via
Business Wire
5 Analysts Have This To Say About Glaukos
March 22, 2024
Via
Benzinga
Glaukos: Q4 Earnings Insights
February 21, 2024
Via
Benzinga
Glaukos Announces Participation in Upcoming Investor Conferences
May 28, 2024
From
Glaukos Corporation
Via
Business Wire
Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst
May 02, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
May 02, 2024
Via
Benzinga
GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q1 2024
May 01, 2024
Via
InvestorPlace
Glaukos Announces First Quarter 2024 Financial Results
May 01, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces the Release of its 2023 Sustainability Report
April 16, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
April 10, 2024
From
Glaukos Corporation
Via
Business Wire
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
April 03, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
April 03, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
April 01, 2024
From
Glaukos Corporation
Via
Business Wire
Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
February 22, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.